top banner
美南廣場 / 董事長介紹

大俠行天下日記 我見我聞我思 09/20

大俠行天下日記 我見我聞我思 09/20

我見 我思 我聞


輝瑞製藥公司週一在一項聲明中宣佈 :经过試驗證明輝瑞疫苗對三分之二的到十一歲的孩童不但安全而且有極強的免疫力





新冠疫情蔓延開來對社會及經濟造成嚴重災情 近二年來無疫苗可打的十六歲以下𠒇成为疫情之最大漏洞感染的孩童无数家庭帶來困擾和煩腦

今天我們面臨之挑戰仍非常嚴峻仍然有近三成的人不相科學研究他們不顧別人之苦痛不願打疫苗 因而上演了多少悲劇


Great News For Our Young Kids

Pfizer made an announcement Monday saying that a Phase 2/3 trial showed its Covid-19 vaccine was safe and generated a “robust” antibody response in children ages 5-11.

This is the first time such results have been released for this age group. Pfizer plans to submit its plan to the U.S. Food and Drug Administration (FDA) for emergency use soon.

The trial included 2,268 people ages 5 to 11 years old. This trial used 10-microgram doses, smaller than the 30-microgram doses used on older than 16 year olds. It demonstrated a strong immune response.

Since July of this year, pediatric cases of Covid-19 have risen 240 percent in the U.S. Pfizer plans to have a vaccine for children ages 5-11 available by Halloween.

U.S. health officials have emphasized that children are not just small adults and even those approaching age 12 should not be given the larger vaccine doses available for older people.

This is really great news for all of us. Over the past several months, many kids have contracted Covid-19 and made life very difficult for their families. Now they might feel a little more relaxed. For now, almost 29% of all Covid-19 cases reported in the U.S. are children under 16.

It has been almost two years now since we all have been suffering from the pandemic that has brought us so much pain. We really appreciate all the scientists who do such a great job to come to the rescue of our society.